MediClin Reports Stable Growth in Challenging Market

MediClin AG has released its Q3 report for 2026, displaying stable business performance despite difficult market conditions. The company treated 82,265 patients in the first nine months, up from 81,564 the previous year. The group operating result increased by 4.1% to EUR 585.9 million, while consolidated EBIT rose to EUR 52.7 million from EUR 48.9 million the previous year.

The Post-Acute segment saw an operating result rise of 3.5% to EUR 399.6 million, though EBIT fell by 5.9% due to higher costs. The Acute segment's operating result increased by 6.0% to EUR 168.3 million, with EBIT reaching EUR 3.1 million. The Care and Service segments showed minor fluctuations in results.

MediClin maintains its forecast for a group operating result increase between 3.5% and 6.5%, and a consolidated EBIT between EUR 57.0 million and EUR 72.0 million for the year.